News

Sandoz Canada announced the launch of Sandoz Olmesartan (olmesartan medoxomil), a generic version of OLMETEC, for the treatment of mild to moderate essential hypertension. This follows…
Read More...

Propanc Biopharma provided an update on the development of the GMP-compliant investigational medicinal product (IMP) manufacture of PRP for First-In-Human studies. PRP is a solution for…
Read More...

AMRI announced it received a 5-year federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for…
Read More...

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, and SightLife Surgical, a cornea-focused organization providing comprehensive services to ophthalmic surgeons,…
Read More...

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that based on positive preclinical data, the…
Read More...

Stealth BioTherapeutics Inc. (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced the initiation of…
Read More...

Bayer announced the appointment of Bhavesh Ashar as senior vice president and head of Oncology for the company's Pharmaceuticals Division in the United States. Ashar will report to…
Read More...

Medicortex Finland Oy, a biotechnology company developing a diagnostic kit for brain injury detection based on a medical breakthrough biomarker, recently completed analyzing the results…
Read More...

Concert Pharmaceuticals announced the initiation of a Phase 2a clinical trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata, an autoimmune disorder in which…
Read More...

NightstaRx Ltd, a biopharmaceutical company specializing in developing gene therapies for inherited retinal dystrophies, announced the appointment of Scott M. Whitcup, M.D. to its board…
Read More...

Be The Match BioTherapies, an organization offering solutions for delivering autologous and allogeneic cellular therapies, today announced that it has entered into a strategic…
Read More...

Verastem focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced the appointment of Eric K. Rowinsky, MD to its Board…
Read More...

Aries Pharmaceuticals, Inc. (Aries) today announced the launch and commercial availability of its first product, Eleview™, a novel, ready to use, submucosal injectable composition for…
Read More...

bluebird bio, Inc. announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with GlaxoSmithKline Intellectual Property…
Read More...

Pillsy, the first smart pill bottle and mobile app that helps users take control of their health and the health of others, has launched and is now available for purchase online. The…
Read More...

bluebird bio announced that it has entered into a worldwide license agreement around its proprietary lentiviral vector platform with Novartis Pharma AG. “bluebird bio is a pioneer in…
Read More...

BioAxone BioSciences, Inc., a clinical-stage biotechnology company focused on developing innovative drugs to restore neurological function, announced that it has entered a contract with…
Read More...

Nanotherapeutics Bohumil s.r.o. (a wholly owned subsidiary of Nanotherapeutics, Inc.) and Cyrus Poonawalla Group announced today the final transfer of Nanotherapeutics Bohumil s.r.o.’s…
Read More...

Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that it has initiated…
Read More...

Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) announced today that the Company will withdraw its European Marketing Authorization Application (MAA) for vosaroxin as a treatment for…
Read More...